HKPD Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares

0.1095USD-2.06%Mkt Cap: 5.40M $P/E: —

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procureme…

Key Statistics

Company
Market Cap5.40M USD
Enterprise Value3.61M USD
Revenue (TTM)13.43M USD
Gross Profit1.39M USD
Net Income (TTM)-1.14M USD
Revenue/Share0.57 USD
Last Price0.1095 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees11
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.93
EV/Revenue0.27
P/S0.40
P/B0.27
EPS (TTM)-0.07
EPS (Forward)—
52W Range
0.09601% of range1.719
52W High1.719 USD
52W Low0.0960 USD
Profitability
Gross Margin10.32%
Oper. Margin-19.32%
EBITDA Margin-6.84%
Profit Margin-8.46%
ROE-11.85%
ROA-8.84%
Growth
Revenue Growth-31.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-751.60K USD
CapEx (TTM)42.54K USD
FCF Margin-48.44%
FCF Yield-120.49%
Net Debt1.04M USD
Net Debt/EBITDA-1.13
Balance Sheet
Debt/Equity0.13
Current Ratio3.86
Quick Ratio1.69
Book Value/Sh0.41 USD
Cash/Share0.0090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.17M
Float16.33M
Insiders17.00%
Institutions0.61%
Short Interest
Short Ratio0.0d
Short % Float0.60%
Short % Out.0.40%
Shares Short199.07K
Short (prev mo.)374.80K
Technical
SMA 500.2734 (-59.9%)
SMA 2000.5346 (-79.5%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)7.10M
Avg Vol (10d)425.11K
Technical Indicators
RSI (14)26.3
MACD-0.0450
MACD Signal-0.0542
MACD Hist.+0.0093
BB Upper0.1315 USD
BB Middle0.1187 USD
BB Lower0.1060 USD
BB Width21.51%
ATR (14)0.0214 USD
Vol Ratio (20d)0.05x